Warjri Gazella Bruce, Das Anthony Vipin, Goyal Yashas, Rao Aparna, Senthil Sirisha
VST Centre for Glaucoma Services, L V Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, Telangana, India.
Department of EyeSmart EMR and AEye, L V Prasad Eye Institute, Hyderabad, Telangana, India.
Indian J Ophthalmol. 2025 May 1;73(5):764-768. doi: 10.4103/IJO.IJO_1998_24. Epub 2025 Apr 24.
To describe the demographics and clinical profile of pseudoexfoliation-like (PXFL) material in young patients.
In this cross-sectional, hospital-based study, the participants were children aged ≤16 years who were observed to have PXFL material in at least one eye. The data of patients presenting between August 2010 and December 2021 were collected using an electronic medical record system and analyzed.
Seventy-five patients (87 eyes) aged ≤16 years were observed to have PXFL material. Unilateral involvement was seen in 72.4% of the eyes. Moreover, 96.5% of the eyes had undergone an intraocular procedure, with 49.4% having undergone a single intraocular procedure and 50.5% multiple intraocular procedures. Appearance of the PXFL material was noted 260 (4-728) weeks after the primary surgery. Glaucoma was seen in 26.4% of the eyes. The most common location of the PXFL material was the pupillary margin (72.4%) followed by the rest of the iris (27.5%).
Appearance of PXFL material in young patients has a close association with an intraocular procedure, with one-fourth of the cases having glaucoma. Stress should be laid on careful anterior segment examination of young patients who have undergone an intraocular procedure. The pathophysiology and prognosis are still unknown.
描述年轻患者中类假性剥脱(PXFL)物质的人口统计学特征和临床概况。
在这项基于医院的横断面研究中,参与者为年龄≤16岁且至少一只眼睛观察到有PXFL物质的儿童。使用电子病历系统收集并分析2010年8月至2021年12月期间就诊患者的数据。
观察到75例(87只眼)年龄≤16岁的患者有PXFL物质。72.4%的眼睛为单侧受累。此外,96.5%的眼睛接受过眼内手术,其中49.4%接受过单次眼内手术,50.5%接受过多次眼内手术。PXFL物质在初次手术后260(4 - 728)周出现。26.4%的眼睛患有青光眼。PXFL物质最常见的位置是瞳孔缘(72.4%),其次是虹膜的其他部位(27.5%)。
年轻患者中PXFL物质的出现与眼内手术密切相关,四分之一的病例患有青光眼。对于接受过眼内手术的年轻患者,应重视仔细的眼前节检查。其病理生理学和预后仍不清楚。